Sunnybrook Health Sciences Centre
Early palliative care reduces aggressive end-of-life care for women with ovarian cancer
Early receipt of palliative care appeared linked to less aggressive end-of-life care for women with ovarian cancer, according to study results.
‘Practice-changing’ radioligand therapy may ‘redefine’ treatment of neuroendocrine tumors
Adding radioligand therapy to first-line treatment of grade 2 or grade 3 gastroenteropancreatic neuroendocrine tumors conferred a significant reduction in risk for disease progression or death, results of a randomized study showed.
Greater CV, all-cause readmissions after acute MI for younger women vs. men
Younger women are much more likely than younger men to be readmitted to the hospital after an acute MI for CV or any cause, with data reflecting a higher prevalence of CV risk factors and comorbidities among women compared with men.
Radiation technique reduces symptomatic esophagitis in patients with advanced lung cancer
Esophageal-sparing intensity-modulated radiotherapy did not significantly improve esophageal quality of life but reduced incidence of symptomatic esophagitis among patients with advanced non-small cell lung cancer.
Patient-reported outcomes linked to nonfatal self-injury after cancer diagnosis
Self-reported signs of distress and an increasing total Edmonton Symptom Assessment System score within 180 days of cancer diagnosis appeared associated with higher odds of nonfatal, self-inflicted injury, study results showed.
ASH recognizes Choosing Wisely champions
ASH recognized three Choosing Wisely Champions during the ASH Annual Meeting and Exposition, held last month in Atlanta.
Neuroendocrine tumors require individualized treatment approach
Patients with neuroendocrine tumors are at greater risk for cancer-associated death compared with death due to other causes; however, mortality rates vary according to tumor site.